This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Worldwide Cancer Immunotherapy with Artificial Intelligence market.
The 2017 study has 124 pages, 50 tables and figures. Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and lowering care delivery costs. Hospital Artificial Intelligence for Immunotherapy drives sales of analytics systems.
Automated cancer immunotherapies from IBM Watson are implemented with artificial intelligence that looks at patient samples to detect the genetic characteristics of the cancer and isolate the immune particularities of the patient. Systems are able to take a multi-disciplinary integrated approach to looking at imaging and scans. The analysis of patient records, looking for effectiveness of particular treatments is more work than a human can do, the quantity of data is too high, so the artificial intelligence is being used to do that.
Request PDF Sample of Cancer Immunotherapy with Artificial Intelligence Market@ http://www.arcognizance.com/enquiry-sample/93021
Personalized medicine is driving this market opportunity.
Systems are making a significant difference in saving lives.
Memorial Sloan Kettering physician-scientists are among leaders in the field developing groundbreaking immune therapies that are helping to treat several forms of advanced cancer that were previously untreatable. These scientists have played a lead role in developing and testing the immunotherapy drugs known as checkpoint inhibitors that “release the brakes” on the immune system.
Hospital care management can leverage artificial intelligence. Artificial intelligence is useful for providing highly tailored insights about individual patients for the purpose of personalizing immunotherapy care delivery. Artificial intelligence is useful for helping providers effectively address healthcare delivery because it details genetic specificity regarding individual patients.
The intersection of healthcare and artificial intelligence represents a market opportunity. New strategies are being developed by companies to bring A.I. to healthcare. The business challenges around those efforts are being addressed collectively in partnerships and in forums to bring the technology into the market. Artificial intelligence has an impact on patients, doctors, hospitals, clinical facilities, and the healthcare industry overall.
Browse the Complete Report with TOC@ http://www.arcognizance.com/report/cancer-immunotherapy-with-artificial-intelligence-for-hospitals-market-shares-strategies-and-forecasts-worldwide-2017-to-2023
The ability of an intelligent system to learn from data without upfront human intervention brings significant change to the healthcare delivery system. It relies on the use of unsupervised and semi-supervised machine learning techniques. Segmentation, dimensionality reduction, anomaly detection and pattern recognition are replacing supervised manual techniques for diagnosis and care delivery.
According to Susan Eustis, lead author of the team that wrote the study, “Immunotherapy at Memorial Sloan Kettering (MSK) has been making enormous progress in the treatment of cancer. At Memorial Sloan Kettering, immunotherapy is one of the most promising ways to treat, cure, and ultimately prevent cancer. Immunotherapy at MSK has evolved new immune-based treatments for cancer. Researchers have been at the epicenter of new discoveries in the field, and their work is bringing exciting new treatment options to people with cancer.”
Artificial Intelligence for Hospital Cancer Immunotherapy Market Forecasts
Cancer immunotherapy hospital artificial intelligence market system shipments at $7.4 billion in 2023 are forecast to reach $49.4 billion dollars, worldwide by 2023. These artificial intelligence systems represent a very specialized type of care delivery. Steady growth is anticipated because the severely ill patients with advanced cancer disease can be treated successfully with immunotherapy.
Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, electronics.ca, Bloomberg, and Thompson Financial.
Place Purchase Order@ http://www.arcognizance.com/purchase/93021
Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise. Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.
Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.
Companies Profiled
Market Leaders
General Electric
IBM
Market Participants
Alphabet / Google
GlaxoSmithKline (GSK)
Merck
Prognos
Quest Diagnostics
Safeguard Scientifics
Zebra
Key Topics
Cancer Immunotherapy
Hospital Artificial Intelligence
AI Technology
Acurate Diagnosis
Healthcare Artificial Intelligence
Supervised machine learning
AI hospital techniques
AI Segmentation
AI dimensionality reduction
AI anomaly detection
AI pattern recognition
AI Replaces Supervised Manual Techniques for Diagnosis and Care Delivery
YOU MUST HAVE THIS STUDY
Table of Content:
- Cancer Immunotherapy Artificial Intelligence Market
Description and Market Dynamics: 22
1.1 Artificial Intelligence Very Big Breakthrough in Cancer Immunotherapy 22
1.2 Ability of AI Solutions To Discover Schemas in Large Databases 23
- Cancer Immunotherapeutic Artificial Intelligence (AI)
Market Driving Forces 25
2.1 Cancer Immunotherapeutic Artificial Intelligence (AI) Market Driving Forces
25
2.2 Artificial Intelligence Oncology Treatment Market Shares: 27
2.3 Cancer Immunotherapy Artificial Intelligence for Hospitals Market Forecasts:
30
2.4 Worldwide Checkpoint Inhibitor and Oncology Treatment Market Forecasts
38
2.5 Cancer Statistics 41
2.5.1 Cancer Among The Leading Causes Of Death Worldwide 46
2.6 Hospital Artificial Intelligence (AI) Challenges 49
2.7 Hospital Artificial Intelligence Software Prices: 52
2.8 Hospital Artificial Intelligence Regional Segments: 53
- Cancer Immunotherapy Hospital Artificial Intelligence
Products: 55
3.1 Memorial Sloan Kettering 55
3.1.1 Memorial Sloan Kettering Parker Institute 57
3.1.2 CAR T Immunotherapy 57
3.1.2 T-Cell Therapies from Merck and Bristol-Myers Squibb 58
3.1.3 Memorial Sloan Kettering Cancer Diagnostic Test, MSK-IMPACT 60
3.1.4 Memorial Sloan Kettering Intensified Tumor Testing 61
3.1.5 Memorial Sloan Kettering Effective Sequencing 61
3.1.6 Memorial Sloan Kettering Actionable the most important cancer
geneTargets 62
3.2 MD Anderson Immune Therapy 63
3.2.1 MD Anderson Immune Therapy 65
3.2.2 MD Anderson Personalized Therapy TNBC Cancer Trials 66
3.3 Partners Dana Farber Immunotherapy 67
Lexington, Massachusetts
3.3.1 Advanced Melanoma Has Been The Test Case For The Study Of
Immune Checkpoint-Inhibiting Therapy 68
3.4 Partners HealthCare, IBM, and GE Healthcare 70
3.5 IBM Watson 72
3.5.1 IBM Genomic And Immunotherapy Supercomputing for Patient
Management 75
3.5.2 Mayo Clinic and IBM Watson 76
3.6 Google’s AI Subsidiary DeepMind is Partnering With Another UK hospital 78
3.7 Prognos 78
- Hospital Artificial Intelligence Research and
Technology: 79
4.1 IBM AI Research 79
4.1.1 Neural Representation of Sketch Drawings 80
4.1.2 IBM Watson Health And Broad Institute Launch Major Research
Initiative To Study Why Cancers Become Drug Resistant 81
4.1.3 IBM and Quest Diagnostics 83
4.2 Research at Google 83
4.3 Google and Nvidia Artificial Intelligence 84
- Hospital Artificial Intelligence Companies 86
5.1 Alphabet / Google 86
5.1.1 Google Artificial Intelligence Subsidiary DeepMind Healthcare Initiative
86
5.2 Broad Institute of MIT and Harvard 87
5.3 Foundation Medicine 88
>120k 88
>30 88
>200 88
Cancer Immunotherapy Artificial Intelligence Table of Contents
and List of Figures
Lexington, Massachusetts
5.3.1 Foundation Medicine 89
5.4 General Electric (GE) 90
5.4.1 General Electric Revenue by Segment 91
5.4.2 GE Healthcare and Massachusetts General Artificial Intelligence 91
5.5 Gritstone Oncology 94
5.6 IBM 94
5.6.1 IBM Watson Health 94
5.6.2 IBM Active in BWH, MGH Partnership To Advance Artificial Intelligence
In Health Care 95
5.6.3 IBM Watson Artificial Intelligence for Oncology 96
5.6.4 IBM Watson Genomics by Quest Diagnostics 97
5.6.5 IBM Watson Healthcare Revenue 98
5.6.6 IBM Watson Solutions Software Healthcare Revenue 98
5.7 Juno Therapeutics 100
5.7.1 Juno Therapeutics Power Of Individualized Cancer Treatment 100
5.7.2 Juno Therapeutics CAR and TCR Technologies 101, Continued…
List of tables
Figure 1. T Lymphocycte 12
Figure 2. Cancer Immunotherapeutic Artificial Intelligence (AI) Market Driving
Forces 14
Figure 3. Healthcare Safety Features Implemented by Artificial Intelligence (AI)15
Figure 4. Cancer Immunotherapy Artificial Intelligence Market Shares, Systems,
Dollars, Worldwide, 2016 17
Figure 5. Cancer Immunotherapy Hospital Artificial Intelligence Market
Shipments Forecasts Dollars, Worldwide, 2017-2023 20
Figure 6. Cancer Artificial Intelligence Components 23
Figure 7. Hospital Artificial Intelligence Predictive Functions 24
Cancer Immunotherapy Artificial Intelligence Table of Contents
and List of Figures
Lexington, Massachusetts
Figure 8. Cancer Immunotherapeutic Artificial Intelligence (AI) Market Driving
Forces 25
Figure 9. Healthcare Safety Features Implemented by Artificial Intelligence (AI)26
Figure 10. Cancer Immunotherapy Artificial Intelligence Market Shares, Systems,
Dollars, Worldwide, 2016 28
Figure 11. Cancer Immunotherapy Artificial Intelligence Systems, Market Shares,
Dollars, Worldwide, 2016 29
Figure 12. Cancer Immunotherapy Artificial Intelligence Market Shipments
Forecasts Dollars, Worldwide, 2017-2023 32
Figure 13. Cancer Immunotherapy Artificial Intelligence Market Shipments
Forecasts Dollars, Worldwide, 2017-2023 33
Figure 14. AI Replacements for Supervised Manual Techniques For Diagnosis And
Care Delivery. 34
Figure 15. Hospital Artificial Intelligence Long-Term Goal 35, Continued…
About Us:
ARCognizance is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics" based on the data collection facilities of big data, the face of "business research facilities" has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the "out of the box" developments in the market.
Contact Us:
Matt Wilson
Manager - Global Sales
Analytical Research Cognizance
100 Church Street, 8th floor
Manhattan, New york, 10007
+1 (646) 434-7969, +91 90967 44448
[email protected]
http://www.arcognizance.com/
Felton, 2 March 2019 - Gas Sensor Market is estimated to reach USD 3,436.2 million by 2025 and is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe.
It is exclusively used for gases like arsine, ammonia, mercury vapor, halocarbons or refrigerants, hydrogen cyanide, nitrogen dioxides, phosphine, carbon dioxide, and others.Request a PDF Sample @ https://www.millioninsights.com/industry-reports/gas-sensor-market/request-sampleThe factors that are playing a major role in the growth of gas sensors market are the rising awareness regarding air quality control, government initiatives for safety, greenhouse gas emissions and use of miniaturized wireless sensors.
However, technical challenges/issues related to temperature, size, and energy consumption may restrain the overall market growth in the years to come.
Gas sensor industry is segmented based on product type, technology, end-user, and region.Methyl mercaptan sensor, oxygen/lambda sensors, nitrogen oxide (NOx) sensors, carbon dioxide sensors, carbon monoxide sensors, and other product types are explored in gas sensor market.
The nitrogen oxide (NOx) sector accounted for the substantial market share of gas sensor and is estimated to lead overall market in the years to come.
The reason supplements with positive initiatives for limiting emission levels.Based on technology, infrared (IR), electrochemical, catalytic, semiconductor, PID, semiconductor, solid state/MOS, and others classify gas sensor industry.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
According to the recent report published by Research Corridor, the Global Automated Smart Locker System Market is expected to provide sustainable growth opportunities during the forecast period from 2020 to 2027.
The report titled "Automated Smart Locker System Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2027" offers a holistic view of the Automated Smart Locker System industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others.
Furthermore, the report includes detailed quantitative and qualitative analysis of the global Automated Smart Locker System market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.
Browse Full report on Global Automated Smart Locker System Market report at https://www.researchcorridor.com/automated-smart-locker-system-market/ The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others.
Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.
Automated Smart Locker System Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Petrochemicals market outlook to 2026 report includes the latest predictions of global Petrochemicals market along with geography, therapy area and applications.
The report specifically focuses on different types of Petrochemicals with a special attention of their emergence over the forecast period to 2026.
Browse Petrochemicals Market Research Report https://www.oganalysis.com/industry-reports/212442/petrochemicals-marketThe research report provides objective measures to tap into the future opportunities that will be available over the next six years.
Impact of domestic market conditions, price variations, competition, government policies, healthcare spending, technological and local market conditions are assessed for country level forecasts.
Global spending on healthcare continues to increase significantly with ageing population, increased access to treatment and ongoing advancements in technology.
While growth will remain steady in the developed markets, Asian and other emerging markets will be key for Petrochemicals market growth from 2020 to 2026.
